By

Luke Timmerman

15
Mar
2021

Software for the Cell & Gene Therapy Wave: Vineti’s Amy DuRoss on The Long Run

Today’s guest on The Long Run is Amy DuRoss. Amy is the co-founder and CEO of San Francisco-based Vineti. The company provides software to manage the delicate logistical dance for cell and gene therapies. Vineti has raised about $115 million in three venture rounds of financing. Its backers include Cardinal Health, the big medical distributor, as well as traditional venture...
Read More
4
Mar
2021

Mental Health: A New Frontier for Biotech

Mental health problems were mounting heading into this pandemic. Now, the challenges are bigger and coming in waves. There’s the grief. Think about all the family and friends of the more than 520,000 people who have died. There’s anxiety about getting infected. There’s depression, and loneliness, that stems from social distancing. Addictions to alcohol and drugs are on the rise...
Read More
25
Feb
2021

Pfizer/BioNTech Ace Real-World Test, J&J Faces FDA Scrutiny, & Merck Pays Up

Vaccine news keeps getting better by the day. The number of new people being diagnosed with COVID-19 has been plummeting for weeks. That’s the good news. Read on and synthesize the most important financings, deals, and scientific developments of the week in biotech. Vaccines Let’s start with the best news of the week. Researchers from Israel reported on the Pfizer...
Read More
18
Feb
2021

Biotech as a Beacon for Youth

Biotech has always depended on the ideas and energy of young people. But it’s time to think more broadly about how biotech and young people relate. Let’s start with young people. Recall the column from two weeks ago, which cited a 2017 Pentagon study. That study found that a full 71 percent of Americans between the ages of 18-24 aren’t...
Read More
4
Feb
2021

The Insurrectionist and the Visionary

One photograph captured our contradictions on Jan. 6. There was the man carrying the Confederate flag where it had never flown before – inside the US Capitol. A violent mob, carrying symbols like that and worse, sought to assassinate elected officials and overthrow our democracy. They were sent there by other elected leaders who were telling lies. It was horrific....
Read More
28
Jan
2021

Ideas for an FDA Reboot

The FDA needs to get healthy, and fast. Its credibility as the world’s No. 1 science-based regulator of food and drugs has been tarnished. From the start, it had to play catch-up on RT-PCR diagnostic tests in the wake of CDC’s epic screwup. Partly to make up lost ground, it swung open the floodgates for antibody tests. A Wild West...
Read More
21
Jan
2021

A Bold Idea for the NIH

Too many people don’t believe anymore in the American dream. But if you can’t dream big, you can’t accomplish big things. Today, I’d like to propose a bold idea for the future of biomedical research. Let’s triple the National Institutes of Health budget over the next decade. Impossible? Hear me out. We know the NIH, with a $41.7 billion a...
Read More